By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Insulin > Insulin

Insulin

GMJ
Last updated: 02/06/2026 14:30
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|601 words

Insulin Drug Profile

What is Insulin?

Insulin is a hormone medication that belongs to the class of antidiabetic agents used to control blood sugar levels. It is a synthetic version of the naturally occurring hormone produced by the pancreas that regulates glucose metabolism. Insulin is primarily prescribed for people with diabetes mellitus who cannot produce enough insulin naturally or whose bodies cannot use insulin effectively.

Uses

Insulin has several approved medical uses:

  • Type 1 diabetes mellitus: Essential replacement therapy for patients whose pancreas produces little to no insulin
  • Type 2 diabetes mellitus: Used when oral medications are insufficient to control blood glucose levels
  • Diabetic ketoacidosis: Emergency treatment for severe metabolic complications of diabetes
  • Gestational diabetes: Blood sugar control during pregnancy when dietary modifications are inadequate
  • Hyperkalemia: Hospital treatment to shift potassium into cells and lower dangerous potassium levels

How it works

Insulin works by binding to insulin receptors on cells throughout the body, particularly muscle, fat, and liver cells. This binding triggers these cells to absorb glucose from the bloodstream and either use it for immediate energy or store it for later use. Insulin also inhibits the liver’s production of glucose, helping to maintain normal blood sugar levels between meals.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Low blood sugar (hypoglycemia)
  • Weight gain
  • Injection site reactions (redness, swelling, itching)
  • Lipodystrophy (changes in fat tissue at injection sites)
  • Swelling of hands and feet
  • Headache
  • Dizziness
  • Nausea

Serious side effects requiring immediate medical attention:

  • Severe hypoglycemia with confusion, seizures, or loss of consciousness
  • Severe allergic reactions with difficulty breathing or swallowing
  • Hypokalemia (dangerously low potassium levels)
  • Severe fluid retention leading to heart failure

Warnings and precautions

  • Hypoglycemia risk: Patients must monitor blood glucose regularly and be aware of symptoms of low blood sugar, especially when changing doses, meal timing, or activity levels
  • Pregnancy and breastfeeding: Generally considered safe during pregnancy (Category B) and is often preferred over oral diabetes medications; dosage adjustments may be needed
  • Kidney and liver disease: Patients with impaired kidney or liver function may require dosage adjustments and more frequent monitoring
  • Heart failure: Insulin can cause fluid retention, which may worsen existing heart conditions
  • Injection site rotation: Failure to rotate injection sites can lead to lipodystrophy and unpredictable insulin absorption

Interactions

  • ACE inhibitors: May increase insulin sensitivity and risk of hypoglycemia
  • Beta-blockers: Can mask symptoms of hypoglycemia and prolong recovery from low blood sugar episodes
  • Corticosteroids: Reduce insulin effectiveness and may require dosage increases
  • Alcohol: Can cause delayed hypoglycemia, especially when consumed without food
  • Salicylates (aspirin): High doses may enhance insulin effects and increase hypoglycemia risk
  • Thiazide diuretics: May reduce insulin sensitivity and worsen blood glucose control
  • Chromium supplements: May enhance insulin action and potentially cause hypoglycemia
  • MAO inhibitors: Can increase insulin sensitivity and prolong hypoglycemic effects

Check interactions with the GMJ Interaction Checker

Dosage

Insulin dosing is highly individualized and must be determined by a healthcare provider based on blood glucose monitoring, patient weight, dietary habits, and activity level. Typical starting doses for adults range from 0.2 to 0.6 units per kilogram of body weight per day, divided between rapid-acting and long-acting formulations. Type 1 diabetes patients typically require 0.4-1.0 units/kg/day, while Type 2 diabetes patients may need 0.2-0.6 units/kg/day initially. Dosages are adjusted based on regular blood glucose monitoring and hemoglobin A1C levels. Patients should never adjust their insulin dose without consulting their healthcare provider, as improper dosing can lead to dangerous blood sugar fluctuations.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Insulin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/insulin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
PCOS Name Change Campaign Gains Momentum as Women Seek Better Understanding GLP-1 Weight-Loss Drugs Reduce Breast Cancer Risk by 17% in Largest Study to Date Resistance Training Linked to 27% Reduction in Early Death Risk, Large-Scale Review Finds
In the news
  • PCOS Name Change Campaign Gains Momentum as Women Seek Better Understanding · Jun 9, 2026
  • GLP-1 Weight-Loss Drugs Reduce Breast Cancer Risk by 17% in Largest Study to Date · Jun 6, 2026
  • Resistance Training Linked to 27% Reduction in Early Death Risk, Large-Scale Review Finds · Jun 6, 2026
  • Magnesium Deficiency May Impair Insulin Sensitivity Through Receptor Signaling · May 27, 2026
  • Sleep Deprivation Triggers Cascading Health Damage Across Seven Body Systems Simultaneously · May 27, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
New Blood Tests and Stool Screens Join Colonoscopy as Primary Options for Colorectal Cancer Detection

The American Cancer Society updated colorectal cancer screening guidelines to include blood-based…

PCOS Name Change Campaign Gains Momentum as Women Seek Better Understanding

More than 170 million women worldwide live with PCOS, yet growing advocacy…

Women’s Empowerment Programs in Poor Countries Lack Clear Measurement Standards

A comprehensive scoping review reveals significant gaps in how women's empowerment programs…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Insulin lispro

By
GMJ News Desk
02/06/2026

Insulin glargine

By
GMJ News Desk
02/06/2026

Insulin aspart

By
GMJ News Desk
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up